Potential new target may aid post-stent recovery

Neointimal hyperplasia is a well-documented remodeling of the innermost vascular layer after vascular interventions and is a significant clinical outcome for many, especially people who have undergone cardiovascular procedures. Proliferation and migration of vascular smooth muscle cells (SMCs) in the innermost layer of an artery or vein results in vascular wall thickening, which leads to […]

HOBMT Leadership Change

I am pleased to announce that we have implemented a new leadership structure for the Division of Hematology, Oncology, and Blood & Marrow Transplantation (HOBMT). The missions of the division have been divided operationally into a Section of Oncology led by Mohammed Milhem, MBBS, and a Section of Hematology led by Steven Lentz, MD, PhD. […]

Lentz delivers Sherry Lecture at AHA

Steven R. Lentz, MD, PhD, Hamilton Chair in Hematology and Hematology Section Chief, presented the 2018 Sol Sherry Distinguished Lecture in Thrombosis at the American Heart Association (AHA) Scientific Sessions. In a lecture entitled “Vascular Stress Management: Oxidative Mechanisms in Thrombosis and Stroke,” Dr. Lentz presented an overview of his investigations of reduction oxidation, or […]

Lentz and Zahr Editorial in NEJM

Dr. Steve Lentz and Dr. Firas Zahr shared a byline recently in an editorial published by the New England Journal of Medicine. Drs. Lentz and Zahr responded to a study published in NEJM, which found that by performing a simple test for the presence of a blood-clotting protein, paravalvular leaks can be readily identified and […]

Lentz Named Chair of ATVB Council

Dr. Steven Lentz has recently been elected Chair of the Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB), one of the largest and most active councils of the American Heart Association. This global organization engages members working in a variety of capacities from discovery science to clinical research. The council also organizes a yearly conference […]